Sign up to save your podcasts
Or
Share New Drug Classes for Diabetes Mean New Options
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
New Drug Classes for Diabetes Mean New Options
Dr Cyrus Desouza reviews GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT2 inhibitors, offering advice on which patients may benefit from each class.
View all episodes
By MedscapeDr Cyrus Desouza reviews GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT2 inhibitors, offering advice on which patients may benefit from each class.